Coya Therapeutics, Inc. has Treg therapies for neurodegenerative and autoimmune diseases, targeting ALS, FTD, AD, and PD. However, their lead candidate is now clearly COYA 302. This drug basically ...

Measure K funds have allowed the department to increase ALS staffing with 13 additional paramedics in unincorporated areas of the county.

"I think we’re a little flat right now. We’re not winning our battles, and I think we make it easy on them, they’re getting a little step on us. It’s on everyone, we’ve just got to be ...

Furthermore, genetic and phenotypic variation between patients makes it difficult to uncover and draw conclusions regarding pathogenic mechanisms of ALS in general. The large number of genes and ...

The teams that finished the league phase between ninth and 16th were seeded for the first draw of the knockout phase, and will face a team placed 17th to 24th. The seeded team will, in principle ...